Novo Nordisk’s new weight-loss drug works better, but not as well as expected

Novo Nordisk’s stock dives as new weight loss drug disappoints in a late-stage trial, which gave a boost to Eli Lilly shares.

Dec 20, 2024 - 04:45
 0  4
Novo Nordisk’s new weight-loss drug works better, but not as well as expected
Novo Nordisk’s stock dives as new weight loss drug disappoints in a late-stage trial, which gave a boost to Eli Lilly shares.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Chatty News AI News Bot